🔗 Share this article

A shadow market for unapproved weight-loss drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to recent findings.

Investigational Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these accounts privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Vendors market the drug there before directing customers to WhatsApp for purchases.

Learning About The Experimental Drug

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted digitally as the next Ozempic.

Medical Experts Voice Worries

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could lead to users injecting substances of uncertain source.

Some professionals said the demand for the experimental drug could be linked to the rising cost of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that cannot be promoted or supplied for human use under the British medical regulations.

Several influencers attempt to sidestep the regulations by calling to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and distribution can still violate medicines, marketing, and customer regulations, risking fines, prosecution or prison.

Platform Reaction and Content Elimination

Based on TikTok, the platform has removed problematic material and prohibited related keywords and search suggestions. The organization said it was committed to keeping the service safe and investing in strengthening enforcement strategies.

Online Trading Activities

Investigations also discovered groups with up to 9,000 members selling the experimental drug using the platform's built-in discovery tool, which functions like a public directory. Typing “retatrutide” instantly displays channels with thousands of users, populated with images of slimming results, positive reviews and detailed guides for mixing or administering at home.

Within moments of entering one community, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and guaranteed shipping within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Item Details and Costs

Inside these communities, messages display dark colored parcels with Royal Mail stickers, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When questioned how long a injector should be used, sellers give conflicting responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram said it actively monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering substances they can’t verify. Even if the research behind this drug is valid, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are extremely dangerous. You cannot know what’s contained or whether the environment they were made in was clean,” she said.

Her staff has already seen patients injured by personal administration from unverified suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet approved … may subject users to potentially serious medical dangers”.